Aktiennews03:40finanzen.netEine Frage der ZeitKI-Blase an der Börse um NVIDIA-Aktie und Co. - Darum erwartet Sorokin einen Crash03:39finanzen.netVerkaufsempfehlungen KW 42Auf dem Verkaufszettel: Diese Aktien empfehlen Experten zu verkaufen03:30PR NewswireHindustan Zinc Achieves Highest Ever 2Q Revenue and EBITDA; PAT Surges 19% QoQWerbung03:30PR NewswireHindustan Zinc Achieves Highest Ever 2Q Revenue and EBITDA; PAT Surges 19% QoQ03:26PR NewswireOsier Belle: Sydney's Most Luxurious Outdoor Furniture Finds a New Home03:13PR NewswireNO DEAL -- STO TRANSIT WORKERS WILL BE ON STRIKE EFFECTIVE 12:01 AM, MONDAY, OCTOBER 2003:07finanzen.netReindustrialisierungMarc Andreessen steht hinter Musks 10-Billionen-Dollar-Plan für den Wiederaufbau der USA03:00PR NewswireAntengene Presents Latest ATG-022 Clinical Data at ESMO 2025 Demonstrating Efficacy Across All CLDN18.2 Expression Levels and Exceptional Tolerability03:00PR NewswireSave Now, Travel through March: T'way Air Announces Fall Savings to Korea03:00PR NewswireAntengene Presents Latest ATG-022 Clinical Data at ESMO 2025 Demonstrating Efficacy Across All CLDN18.2 Expression Levels and Exceptional Tolerability02:15PR NewswireCARsgen Presents Preliminary Results on Satri-cel for Adjuvant Therapy of Pancreatic Cancer at ESMO Congress 202502:10PR NewswireESMO 2025: CStone Discloses Phase I Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody)02:10PR NewswireAscletis Completes Enrollment in U.S. Phase IIa Study for Its Once-Monthly Subcutaneous Depot Treatment Formulation of Small Molecule GLP-1R Agonist ASC30 for Obesity02:10PR NewswireAscletis Completes Enrollment in U.S. Phase IIa Study for Its Once-Monthly Subcutaneous Depot Treatment Formulation of Small Molecule GLP-1R Agonist ASC30 for Obesity02:00PR NewswirePrime Minister Celebrates Opening of Cambodia's State-of-the-art International Airport01:30PR NewswireIZERVAY™ (avacincaptad pegol intravitreal solution) Showed Increased Benefit in Reducing Geographic Atrophy Progression Over Time and Consistent Long-Term Safety01:25PR NewswireLeading Competition Economist Dr. Luke Wainscoat Joins The Brattle Group01:00PR NewswireClover Appoints Nicholas Jackson, Ph.D., as President of Global R&D and Alliances00:40PR NewswireLeading Competition Economist Dr. Luke Wainscoat Joins The Brattle Group00:00PR NewswireWebull Reduces Minimum ASX Trading Fee To $119.10.25PR NewswireRazor Labs Expands Predictive Maintenance Coverage in Australia with Mobile Fleet AI Solution Launch at IMARC 202519.10.25PR NewswireRazor Labs Expands Predictive Maintenance Coverage in Australia with Mobile Fleet AI Solution Launch at IMARC 202519.10.25PR NewswireYaber Expands Its Global Footprint -- Now Available at JB Hi-Fi Across Australia19.10.25dpa-afxGESAMT-ROUNDUP: Gaza-Waffenruhe übersteht erste schwere Krise19.10.25dpa-afxROUNDUP: Russischer Angriff auf Kohlegrube123456789...40